{
  "url": "https://finance.yahoo.com/news/aimfinity-investment-corp-announces-monthly-211700114.html?_guc_consent_skip=1756848187",
  "authorsByline": "Aimfinity Investment Corp. I",
  "articleId": "90a45744c6b54819910a52375e25d648",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/globenewswire.com/9127c605fa5a102741e994da48baa5ff",
  "country": "us",
  "language": "en",
  "pubDate": "2025-09-02T21:17:00+00:00",
  "addDate": "2025-09-02T21:24:04.286450+00:00",
  "refreshDate": "2025-09-02T21:24:04.286452+00:00",
  "score": 1.0,
  "title": "Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination",
  "description": "Wilmington, DE, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the \u201cAIMA\u201d) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from August 28, 2025 to September 28, 2025, on August 28, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the \u201cTrust Account\u201d) an aggreg",
  "content": "As previously disclosed, on October 13, 2023, AIMA entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the \u201cMerger Agreement\u201d), by and between AIMA, Docter, Aimfinity Investment Merger Sub I, a Cayman Islands exempted company and wholly-owned subsidiary of AIMA (\u201cPurchaser\u201d), and Aimfinity Investment Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser (\u201cMerger Sub\u201d), pursuant to which AIMA is proposing to enter into a business combination with Docter involving an reincorporation merger and an acquisition merger. This press release does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the business combination. AIMA\u2019s shareholders and other interested persons are advised to read, when available, the proxy statement/prospectus and the amendments thereto and other documents filed in connection with the proposed business combination, as these materials will contain important information about AIMA, Purchaser or Docter, and the proposed business combination. The proxy statement/prospectus and other relevant materials for the proposed business combination have been mailed to shareholders of AIMA as of the record date of February 25, 2025, established for voting on the proposed business combination. Such shareholders will also be able to obtain copies of the proxy statement/prospectus and other documents filed with the SEC, without charge, once available, at the SEC\u2019s website at www.sec.gov, or by directing a request to AIMA\u2019s principal office at 221 W 9th St, PMB 235 Wilmington, Delaware 19801.\n\nPursuant to the Company\u2019s fourth amended & restated memorandum and articles of association (\u201cCurrent Charter\u201d), effectively January 9, 2025, the Company may extend on a monthly basis from January 28, 2025 until October 28, 2025 or such an earlier date as may be determined by its board to complete a business combination by depositing the Monthly Extension Payment for each month into the Trust Account. This is the eighth of nine monthly extensions sought under the Current Charter of the Company.\n\nWilmington, DE, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the \u201cAIMA\u201d) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from August 28, 2025 to September 28, 2025, on August 28, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the \u201cTrust Account\u201d) an aggregate of $55,823.8, or for $0.05 per Class A ordinary share held by public shareholders (the \u201cMonthly Extension Payment\u201d).\n\nThis press release contains certain \u201cforward-looking statements\u201d within the meaning of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d) and the Securities Exchange Act of 1934, as amended. Statements that are not historical facts, including statements about the proposed transactions described herein, and the parties\u2019 perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the proposed transactions. The words \u201cexpect,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cplan\u201d and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.\n\nSuch risks and uncertainties include, but are not limited to: (i) risks related to the expected timing and likelihood of completion of the proposed business combination, including the risk that the transaction may not close due to one or more closing conditions to the transaction not being satisfied or waived, such as regulatory approvals not being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed or refused to grant approval for the consummation of the transaction or required certain conditions, limitations or restrictions in connection with such approvals; (ii) risks related to the ability of AIMA and Docter to successfully integrate the businesses; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the applicable transaction agreements; (iv) the risk that there may be a material adverse change with respect to the financial position, performance, operations or prospects of AIMA or Docter; (v) risks related to disruption of management time from ongoing business operations due to the proposed transaction; (vi) the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of AIMA\u2019s securities; (vii) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Docter to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally; (viii) risks relating to the medical device industry, including but not limited to governmental regulatory and enforcement changes, market competitions, competitive product and pricing activity; and (ix) risks relating to the combined company\u2019s ability to enhance its products and services, execute its business strategy, expand its customer base and maintain stable relationship with its business partners.\n\nA further list and description of risks and uncertainties can be found in the prospectus filed with the Securities and Exchange Commission (the \u201cSEC\u201d) on April 26, 2022 relating to AIMA\u2019s initial public offering (File No. 333-263874), the annual report of AIMA on Form 10-K for the fiscal year ended on December 31, 2024, filed with the SEC on April 15, 2025, and in the final prospectus/proxy statement filed with the SEC on March 6, 2025 relating to the proposed transactions (File No. 333-284658) (the \u201cFinal Prospectus\u201d), and other documents that the parties may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and AIMA, Docter, and their subsidiaries or affiliates undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.\n\nAdditional Information and Where to Find It\n\nIn connection with the proposed transactions described herein, Purchaser filed the Final Prospectus with the SEC on March 6, 2025. The proxy statement and a proxy card has been mailed to AIMA\u2019s shareholders of record as of February 25, 2025. Shareholders of AIMA will also be able to obtain a copy of the Final Prospectus without charge from AIMA. The Final Prospectus may also be obtained without charge at the SEC\u2019s website at www.sec.gov. INVESTORS AND SECURITY HOLDERS OF AIMA ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE PROPOSED TRANSACTIONS THAT AIMA WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AIMA, DOCTER AND THE PROPOSED TRANSACTIONS.\n\nAIMA, Docter, and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of AIMA\u2019s shareholders in connection with the proposed transactions described herein. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of AIMA\u2019s shareholders in connection with the proposed business combination is set forth in the Final Prospectus.\n\nThis press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of any potential transaction and does not constitute an offer to sell or a solicitation of an offer to buy any securities of AIMA, Purchaser or Docter, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.",
  "medium": "Article",
  "links": [],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Business Combination",
      "weight": 0.07825786
    },
    {
      "name": "AIMA",
      "weight": 0.07583765
    },
    {
      "name": "Such statements",
      "weight": 0.0714631
    },
    {
      "name": "Such risks",
      "weight": 0.069839284
    },
    {
      "name": "businesses",
      "weight": 0.06421496
    },
    {
      "name": "ongoing business operations",
      "weight": 0.06261655
    },
    {
      "name": "Such shareholders",
      "weight": 0.06008846
    },
    {
      "name": "Statements",
      "weight": 0.058920503
    },
    {
      "name": "statements",
      "weight": 0.058920503
    },
    {
      "name": "other documents",
      "weight": 0.05750449
    }
  ],
  "topics": [
    {
      "name": "Mergers and Acquisitions"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Company News",
      "score": 0.9970703125
    },
    {
      "name": "/Finance/Investing/Other",
      "score": 0.89208984375
    },
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.7646484375
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.5048828125
    }
  ],
  "sentiment": {
    "positive": 0.14166287,
    "negative": 0.07712427,
    "neutral": 0.78121287
  },
  "summary": "Aimfinity Investment Corp. I (AIMA) (Nasdaq: AIMTF), a Cayman Islands exempted company and wholly-owned subsidiary of AIMA (Purchaser), and Aimfinity investment Merger Sub II, Inc., a Delaware corporation and subsidiary of Purchaser (Merger Sub), are proposing to enter into a business combination with Docter, a merger involving an reincorporation merger and an acquisition merger. The company may extend this monthly extension from January 28, 2025 until October 28, 25, or such an earlier date as may be determined by its board to complete a business merger by depositing the Monthly Extension Payment for each month into the Trust Account. This is the eighth of nine monthly extensions sought under the Current Charter of the company. Shareholders can access copies of the proxy statement/prospectus and other documents filed with the SEC without charge at the SEC's website at www.sec.gov or by directing a request to AIMAA\u2019s principal office at 221 W 9th St, PMB 235 Wilmington, Delaware 19801.",
  "shortSummary": "Aimfinity Investment Corp. I announces a monthly extension of the proposed business combination with Docter, potentially involving a reincorporation merger, with potential regulatory risks and uncertainties.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "4d8035e1c783426bbc87328691ca5fd9",
  "places": [],
  "scraped_sources": [],
  "argos_summary": "Aimfinity Investment Corp. I (AIMA) announced a new monthly extension for its proposed business combination with Docter, extending the deadline from August 28, 2025 to September 28, 2025. The sponsor\u2019s manager, I\u2011Fa Chang, deposited $55,823.8\u2014$0.05 per Class\u202fA share\u2014into AIMA\u2019s trust account to secure the extension. This marks the eighth of nine monthly extensions allowed under AIMA\u2019s charter, underscoring the ongoing effort to complete the transaction before the new deadline.",
  "argos_id": "SWH8M7Y0J"
}